breakthrough device designation
Renovos Biologics gains FDA Breakthrough Device Designation for Renovite
January 4, 2024Medical Communications FDA, Musculo-skeletal disorder, Renovos Biologics, breakthrough device designation
Renovos Biologics has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its lead …
Tempus receives FDA Breakthrough Device Designation for its companion diagnostic test
August 16, 2023Research and Development Diagnostics, FDA, Tempus, breakthrough device designation, diagnostic
Tempus has announced that the US Food and Drug Administration (FDA) has granted it Breakthrough Device Designation for its HLA-LOH …
Cognixion receives FDA Breakthrough Device Designation for assisted communication device
May 5, 2023Medical Communications Cognixion, FDA, Neurology, brain computer interface, breakthrough device designation, neuroscience
Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and …
Latest content
Global coalition calls for stronger government action on COPD
September 18, 2026
Global health researchers call for more equitable partnerships
September 17, 2026
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026
Circle Health Group expands into UK laboratory operations
September 15, 2026
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
September 14, 2026
